BACKGROUND: With improved access to antiretroviral therapy in resource-constrained settings, long-term retention in HIV clinics has become an important means of reducing costs and improving outcomes. Published data on retention in HIV clinics beyond 24 months are, however, limited. In our clinic in rural Haiti, we hypothesized that individuals residing in locations with higher transportation costs to clinic would have poorer retention than those who had lower costs. METHODS: We used a retrospective cohort design to evaluate potential predictors of HIV clinic retention. Patient information was abstracted from the electronic medical records. Cox proportional hazards regression was used to identify independent predictors of 4-year clinic retention. RESULTS: There were 410 patients in our cohort, 266 (64.9%) females and 144 (35.1%) males. Forty-five (11%) patients lived in locations with transportation costs >$2. Males were 1.5 times more likely to live in municipalities with transportation costs to clinic of >$2. Multivariate analysis suggested that age <30 years, male gender, and transportation cost were independent predictors of loss to follow-up (LTFU): risk ratio of 2.98, 95% confidence interval (CI): 1.73 to 4.96, P < 0.001; 1.71, CI: 1.08 to 2.70, P = 0.02; and 1.91, CI: 1.08 to 3.36, P = 0.02, respectively. CONCLUSIONS: Patients with transportation costs greater than $2 were 1.9 times more likely to be lost to care compared with those who paid less for transportation. HIV treatment programs in resource-constrained settings may need to pay closer attention to issues related to transportation cost to improve patient retention.
BACKGROUND: With improved access to antiretroviral therapy in resource-constrained settings, long-term retention in HIV clinics has become an important means of reducing costs and improving outcomes. Published data on retention in HIV clinics beyond 24 months are, however, limited. In our clinic in rural Haiti, we hypothesized that individuals residing in locations with higher transportation costs to clinic would have poorer retention than those who had lower costs. METHODS: We used a retrospective cohort design to evaluate potential predictors of HIV clinic retention. Patient information was abstracted from the electronic medical records. Cox proportional hazards regression was used to identify independent predictors of 4-year clinic retention. RESULTS: There were 410 patients in our cohort, 266 (64.9%) females and 144 (35.1%) males. Forty-five (11%) patients lived in locations with transportation costs >$2. Males were 1.5 times more likely to live in municipalities with transportation costs to clinic of >$2. Multivariate analysis suggested that age <30 years, male gender, and transportation cost were independent predictors of loss to follow-up (LTFU): risk ratio of 2.98, 95% confidence interval (CI): 1.73 to 4.96, P < 0.001; 1.71, CI: 1.08 to 2.70, P = 0.02; and 1.91, CI: 1.08 to 3.36, P = 0.02, respectively. CONCLUSIONS:Patients with transportation costs greater than $2 were 1.9 times more likely to be lost to care compared with those who paid less for transportation. HIV treatment programs in resource-constrained settings may need to pay closer attention to issues related to transportation cost to improve patient retention.
Authors: Marco T Luque; Cathy A Jenkins; Bryan E Shepherd; Denis Padgett; Vanessa Rouzier; Regina Célia M Succi; Daisy M Machado; Catherine C McGowan; Sten H Vermund; Jorge A Pinto Journal: J Pediatr Date: 2017-01-09 Impact factor: 4.406
Authors: John A Naslund; Jodie Dionne-Odom; Cléonas Junior Destiné; Kristen M Jogerst; Redouin Renold Sénécharles; Michelande Jean Louis; Jasmin Desir; Yvette Néptune Ledan; Jude Ronald Beauséjour; Roland Charles; Alice Werbel; Elizabeth A Talbot; Patrice Joseph; Jean William Pape; Peter F Wright Journal: AIDS Res Treat Date: 2014-12-07
Authors: Madeline C Montgomery; Zachary Alholm; Alexi Almonte; Kevin J Sykes; Gregory Rudolph; Brandon Cusick; Laura Castello; Genoviva Sowemimo-Coker; Irene Tang; Sarah Haberlack; Philip A Chan Journal: BMC Womens Health Date: 2020-02-07 Impact factor: 2.809
Authors: Macarthur Charles; Milo Richard; Mary R Reichler; Jean Baptiste Koama; Willy Morose; David L Fitter Journal: PLoS One Date: 2021-03-17 Impact factor: 3.240
Authors: Deanna P Jannat-Khah; Michelle Unterbrink; Margaret McNairy; Samuel Pierre; Dan W Fitzgerald; Jean Pape; Arthur Evans Journal: BMC Public Health Date: 2018-11-19 Impact factor: 3.295
Authors: Lily D Yan; Dufens Pierre-Louis; Benito D Isaac; Waking Jean-Baptiste; Serge Vertilus; Darius Fenelon; Lisa R Hirschhorn; Patricia L Hibberd; Emelia J Benjamin; Gene Bukhman; Gene F Kwan Journal: BMC Public Health Date: 2020-10-14 Impact factor: 3.295